跳轉至內容
Merck
全部照片(1)

文件

SML0124

Sigma-Aldrich

甲磺酸雷沙吉兰 甲磺酸酯

≥98% (HPLC)

同義詞:

(R)-N-2-丙炔基-1-氢化茚胺甲磺酸盐 甲磺酸酯, TVP-1012, 马来酸雷沙吉兰 甲磺酸酯

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C12H13N · CH4O3S
CAS號碼:
161735-79-1
分子量：:
267.34
MDL號碼:
MFCD08460604
分類程式碼代碼:
12352200
PubChem物質ID:
329825174
NACRES:
NA.77

化驗

≥98% (HPLC)

形狀

powder

光學活性

[α]/D +15 to +28°, c = 0.6 mg/mL in H2O

儲存條件

desiccated

顏色

white to tan

溶解度

H2O: ≥20 mg/mL

儲存溫度

2-8°C

SMILES 字串

CS(O)(=O)=O.C#CCN[C@@H]1CCc2ccccc12

InChI

1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1

InChI 密鑰

JDBJJCWRXSVHOQ-UTONKHPSSA-N

基因資訊

human ... MAOB(4129)

應用

甲磺酸雷沙吉兰可被用于MAO B型介导的细胞信号转导研究。
甲磺酸雷沙吉兰已被用于：
  • 通过细胞凋亡调节因子Bax/Bcl-2的调节来检测其对视网膜色素变性（RP）的神经保护作用
  • 在1-甲基-4-苯基-1,2,3,6-四氢吡啶（MPTP）诱导的小鼠模型中用作单胺氧化酶-B抑制剂
  • 作为一种抗帕金森病药物，用于测试其对6-羟基多巴胺损伤的斑马鱼幼体运动迟缓和运动障碍样行为的拯救功能

生化／生理作用

甲磺酸雷沙吉兰是单胺氧化酶的一种不可逆抑制剂，其对B型MAO的选择性比A型高十四倍。它具有抗凋亡和神经保护活性，并已被用于治疗帕金森病。
甲磺酸雷沙吉兰是帕金森病早期的一种有效治疗选择。它可改善左旋多巴治疗患者的运动波动，并对此类患者可能是一种有用辅助手段。它具有神经保护作用并可增加多巴胺能神经元的存活。

特點和優勢

该化合物是《受体分类及信号转导》手册上多巴胺和去甲肾上腺素代谢 和 组胺合成和代谢页面上的推荐化合物。想要浏览手册的其他页面， 请单击此处。

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Rita L Vaz et al.
Pharmacology, biochemistry, and behavior, 189, 172828-172828 (2019-12-01)
Parkinson's disease (PD) is known as a movement disorder due to characteristic motor features. Existing therapies for PD are only symptomatic, and their efficacy decreases as disease progresses. Zebrafish, a vertebrate in which parkinsonism has been modelled, offers unique features
Dhaval R Kalaria et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 127, 204-212 (2018-02-27)
Effective treatment of Parkinson's disease (PD) involves administration of therapeutic agents with complementary mechanisms of action in order to replenish, sustain or substitute endogenous dopamine. The objective of this study was to investigate anodal co-iontophoresis of pramipexole (PRAM; dopamine agonist)
J M Rabey et al.
Clinical neuropharmacology, 23(6), 324-330 (2001-09-29)
Rasagiline mesylate (TVP-1012) is a potent, selective, non-reversible MAO-B inhibitor, without the tyramine-potentiating effect and with neuroprotective activities. The benefit of rasagiline as monotherapy in patients with early Parkinson's disease (PD) has already been reported. To evaluate the safety, tolerability
J P Finberg et al.
Neuroreport, 9(4), 703-707 (1998-04-29)
Both deprenyl and rasagiline (R(+)-N-propargyl-1-aminoindane mesylate), at a concentration of 1-10 microM, increased survival in vitro of rat E14 mesencephalic dopaminergic neurons that had been primed with 10% serum for 12 h (p < 0.05). Rasagiline, but not deprenyl, also
O Rascol et al.
Lancet (London, England), 365(9463), 947-954 (2005-03-16)
Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as monotherapy in early disease. This study investigated rasagiline efficacy and safety in levodopa-treated patients with Parkinson's disease and
查看所有相關論文

文章

Serotonin Synthesis and Metabolism

Serotonin (5-hydroxytryptamine) is principally found stored in three main cell types - i) serotonergic neurons in the CNS and in the intestinal myenteric plexus, ii) enterochromaffin cells in the mucosa of the gastrointestinal tract, and iii) in blood platelets. Metabolism of serotonin is carried out primarily by the outer mitochondrial membrane enzyme monoamine oxidase (MAO), which occurs as two molecular subtypes called MAO-A and MAO-B.

Histamine Synthesis and Metabolism

Our company offers many products related to histamine synthesis and metabolism for your research needs.

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務